Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 139 articles: HTML format Text format

Single Articles

January 2012
1. DECKER RH , Lynch TJ
   Unmet Challenges in the Use of Novel Agents in Locally Advanced Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. HOANG T , Dahlberg SE, Schiller JH, Mehta MP, et al
   Randomized Phase III Study of Thoracic Radiation in Combination With Paclitaxel and Carboplatin With or Without Thalidomide in Patients With Stage III Non-Small-Cell Lung Cancer: The ECOG 3598 Study.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. HOU JM , Krebs MG, Lancashire L, Sloane R, et al
   Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. JANNE PA , Meyerson M
   ROS1 Rearrangements in Lung Cancer: A New Genomic Subset of Lung Adenocarcinoma.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
5. SU KY , Chen HY, Li KC, Kuo ML, et al
   Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. GREER JA , Pirl WF, Jackson VA, Muzikansky A, et al
   Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients With Metastatic Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. DE PAS TM , Giovannini M, Manzotti M, Trifiro G, et al
   Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib.
   J Clin Oncol. 2011;29:e819-22.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
8. STRAUSS GM
   Induction Chemotherapy and Surgery for Early-Stage Non-Small-Cell Lung Cancer: What Have We Learned From Randomized Trials?
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. SCAGLIOTTI GV , Pastorino U, Vansteenkiste JF, Spaggiari L, et al
   Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LEVY A , Magne N, Chargari C
    Computed tomography-based simulation for thoracic radiation therapy: technical advance or clinical evidence?
    J Clin Oncol. 2011;29:4335-6.
    PubMed     Text format     Related articles   
    
    
    
    
11. CHANG PH , Hung MJ, Yeh KY, Yang SY, et al
    Oxaliplatin-induced coronary vasospasm manifesting as Kounis syndrome: a case report.
    J Clin Oncol. 2011;29:e776-8.
    PubMed     Text format     Related articles   
    
    
    
    
12. SEOW H , King S, Green E, Pereira J, et al
    Perspectives of patients on the utility of electronic patient-reported outcomes on cancer care.
    J Clin Oncol. 2011;29:4213-4.
    PubMed     Text format     Related articles   
    
    
    
    October 2011
13. RAMALINGAM SS , Spigel DR, Chen D, Steins MB, et al
    Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ILHAN A , Furtner J, Birner P, Rossler K, et al
    Myxopapillary ependymoma with pleuropulmonary metastases and high plasma glial fibrillary acidic protein levels.
    J Clin Oncol. 2011;29:e756-7.
    PubMed     Text format     Related articles   
    
    
    
    
15. SORIA JC , Mark Z, Zatloukal P, Szima B, et al
    Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. GROEN HJ , Sietsma H, Vincent A, Hochstenbag MM, et al
    Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. RUSCH VW , Hawes D, Decker PA, Martin SE, et al
    Occult Metastases in Lymph Nodes Predict Survival in Resectable Non-Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SHEPHERD FA
    Maintenance Therapy Comes of Age for Non-Small-Cell Lung Cancer, but at What Cost?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
19. PARIKH PM , Vaid A, Advani SH, Digumarti R, et al
    Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer That Progressed After Chemotherapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. READY NE , Dudek AZ, Pang HH, Hodgson LD, et al
    Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. BRUGGER W , Triller N, Blasinska-Morawiec M, Curescu S, et al
    Prospective Molecular Marker Analyses of EGFR and KRAS From a Randomized, Placebo-Controlled Study of Erlotinib Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SWERDLOW AJ , Higgins CD, Smith P, Cunningham D, et al
    Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
23. WANG LE , Yin M, Dong Q, Stewart DJ, et al
    DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non-Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. KOSHY M
    Is computed tomography simulation associated with improved survival, or is this finding a result of confounding variables?
    J Clin Oncol. 2011;29:3587.
    PubMed     Text format     Related articles   
    
    
    
    
25. AZZOLI CG , Temin S, Aliff T, Baker S Jr, et al
    2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. YUAN S , Yu SL, Chen HY, Hsu YC, et al
    Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
    J Clin Oncol. 2011;29:3435-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. WRIGHT JD , Neugut AI, Wilde ET, Buono DL, et al
    Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.
    J Clin Oncol. 2011;29:3408-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
28. GARASSINO MC , Marsoni S, Floriani I
    Testing Epidermal Growth Factor Receptor Mutations in Patients With Non-Small-Cell Lung Cancer to Choose Chemotherapy: The Other Side of the Coin.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
29. QUINTELA-FANDINO M , Colomer R
    Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
30. MAITLAND ML , Bies RR, Barrett JS
    A time to keep and a time to cast away categories of tumor response.
    J Clin Oncol. 2011;29:3109-11.
    PubMed     Text format     Related articles   
    
    
    
    
31. OXNARD GR , Zhao B, Sima CS, Ginsberg MS, et al
    Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes.
    J Clin Oncol. 2011;29:3114-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TACHIHARA M , Misa K, Uematsu M, Minemura H, et al
    Increase of ascites and pleural effusion misleading assessment of antitumor response to erlotinib in adenocarcinoma of the lung.
    J Clin Oncol. 2011;29:e675-7.
    PubMed     Text format     Related articles   
    
    
    
    
33. KAWAKAMI H , Sugioka K, Yonesaka K, Satoh T, et al
    Human epidermal growth factor eyedrops for cetuximab-related filamentary keratitis.
    J Clin Oncol. 2011;29:e678-9.
    PubMed     Text format     Related articles   
    
    
    
    
34. HIRSCH FR , Kabbinavar F, Eisen T, Martins R, et al
    A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MARCHETTI A , Felicioni L, Malatesta S, Sciarrotta MG, et al
    Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. YATABE Y , Matsuo K, Mitsudomi T
    Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.
    J Clin Oncol. 2011;29:2972-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LORUSSO PM , Boerner SA, Hunsberger S
    Clinical development of vascular disrupting agents: what lessons can we learn from ASA404?
    J Clin Oncol. 2011;29:2952-5.
    PubMed     Text format     Related articles   
    
    
    
    
38. MEHMOOD QU , Shaktawat SS, Parikh O
    Case of rhabdomyosarcoma presenting with myasthenia gravis.
    J Clin Oncol. 2011;29:e653-5.
    PubMed     Text format     Related articles   
    
    
    
    
39. LEWIS MA
    Gain of function: empathy for the uncertain patient with cancer.
    J Clin Oncol. 2011;29:3103-4.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
40. ZHOU Q , Zhang XC, Chen ZH, Yin XL, et al
    Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SHEPHERD FA
    Molecular selection trumps clinical selection.
    J Clin Oncol. 2011;29:2843-4.
    PubMed     Text format     Related articles   
    
    
    
    
42. KAUR-KNUDSEN D , Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG, et al
    Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.
    J Clin Oncol. 2011;29:2875-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. GOTTSCHLING S , Penzel R, Pelz T, Herpel E, et al
    KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib: a case report and review of the literature.
    J Clin Oncol. 2011;29:e616-9.
    PubMed     Text format     Related articles   
    
    
    
    
44. SEQUIST LV , von Pawel J, Garmey EG, Akerley WL, et al
    Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. FISCHER AH , Cibas ES, Howell LP, Kurian EM, et al
    Role of Cytology in the Management of Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
46. GOVINDAN R , Bogart J, Stinchcombe T, Wang X, et al
    Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
47. LARA PN JR , Douillard JY, Nakagawa K, von Pawel J, et al
    Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. CLEELAND CS , Mendoza TR, Wang XS, Woodruff JF, et al
    Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. BOURHIS J , Blanchard P, Maillard E, Brizel DM, et al
    Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
    J Clin Oncol. 2011;29:2590-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. DE VINCENZO F , Zucali PA, Ceresoli GL, Colombo P, et al
    Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    J Clin Oncol. 2011;29:e529-31.
    PubMed     Text format     Related articles   
    
    
    
    
51. FUKUOKA M , Wu YL, Thongprasert S, Sunpaweravong P, et al
    Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS).
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. BEZJAK A
    Harnessing radiation technology to improve survival.
    J Clin Oncol. 2011;29:2295-6.
    PubMed     Text format     Related articles   
    
    
    
    
53. YANG TY , Tsai CR, Chen KC, Hsu KH, et al
    Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.
    J Clin Oncol. 2011;29:e468-9.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
54. HIRSH V , Paz-Ares L, Boyer M, Rosell R, et al
    Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. VAN DOORMAAL FF , Di Nisio M, Otten HM, Richel DJ, et al
    Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer.
    J Clin Oncol. 2011;29:2071-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. PAIK PK , Arcila ME, Fara M, Sima CS, et al
    Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations.
    J Clin Oncol. 2011;29:2046-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. D'ANGELO SP , Pietanza MC, Johnson ML, Riely GJ, et al
    Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas.
    J Clin Oncol. 2011;29:2066-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SPIGEL DR , Burris HA 3rd, Greco FA, Shipley DL, et al
    Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TEMEL JS , Greer JA, Admane S, Gallagher ER, et al
    Longitudinal Perceptions of Prognosis and Goals of Therapy in Patients With Metastatic Non-Small-Cell Lung Cancer: Results of a Randomized Study of Early Palliative Care.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. BLUMENSCHEIN GR JR , Paulus R, Curran WJ, Robert F, et al
    Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small-Cell Lung Cancer: RTOG 0324.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. CHEN AB , Neville BA, Sher DJ, Chen K, et al
    Survival Outcomes After Radiation Therapy for Stage III Non-Small-Cell Lung Cancer After Adoption of Computed Tomography-Based Simulation.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
62. WICHA MS , Hayes DF
    Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.
    J Clin Oncol. 2011;29:1508-11.
    PubMed     Text format     Related articles   
    
    
    
    
63. HSIAO YW , Lin YC, Hui RC, Yang CH, et al
    Fulminant acneiform eruptions after administration of dovitinib in a patient with renal cell carcinoma.
    J Clin Oncol. 2011;29:e340-1.
    PubMed     Text format     Related articles   
    
    
    
    
64. SPIGEL DR , Townley PM, Waterhouse DM, Fang L, et al
    Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. STANESCU-SEGALL D , Wilson C, Bonnel S, Heligon JP, et al
    Seventeen-Year Survival of Small-Cell Lung Carcinoma Presenting As Carcinoma-Associated Retinopathy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
66. KIJIMA T , Shimizu T, Nonen S, Furukawa M, et al
    Safe and Successful Treatment With Erlotinib After Gefitinib-Induced Hepatotoxicity: Difference in Metabolism As a Possible Mechanism.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
67. BUNN PA JR , Doebele RC
    Genetic Testing for Lung Cancer: Reflex Versus Clinical Selection.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
68. KEEDY VL , Temin S, Somerfield MR, Beasley MB, et al
    American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CLAASSENS L , van Meerbeeck J, Coens C, Quinten C, et al
    Health-Related Quality of Life in Non-Small-Cell Lung Cancer: An Update of a Systematic Review on Methodologic Issues in Randomized Controlled Trials.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. KURITA GP , Sjogren P, Ekholm O, Kaasa S, et al
    Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
    J Clin Oncol. 2011;29:1297-303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. PALMER SC , van Scheppingen C, Coyne JC
    Clinical trial did not demonstrate benefits of screening patients with cancer for distress.
    J Clin Oncol. 2011;29:e277-8.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
72. RAMALINGAM SS , Lee JW, Belani CP, Aisner SC, et al
    Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504).
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. ZANDER T , Scheffler M, Nogova L, Kobe C, et al
    Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. KREBS MG , Sloane R, Priest L, Lancashire L, et al
    Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. COSTA DB , Kobayashi S, Pandya SS, Yeo WL, et al
    CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
76. HOTTA K , Takigawa N, Matsuo K, Kiura K, et al
    Cure- or Care-Oriented Regimen for Stage III Non-Small-Cell Lung Cancer?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
77. CLEELAND CS , Wang XS, Shi Q, Mendoza TR, et al
    Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.
    J Clin Oncol. 2011;29:994-1000.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. VON DER THUSEN JH , van de Wetering MD, Westermann AM, Heideman DA, et al
    Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.
    J Clin Oncol. 2011;29:e188-90.
    PubMed     Text format     Related articles   
    
    
    
    
79. LEE SY , Shim JJ, Kang KH, Shin BK, et al
    Curious case of combined small- and squamous cell carcinoma.
    J Clin Oncol. 2011;29:e186-7.
    PubMed     Text format     Related articles   
    
    
    
    
80. OHTSUKA K , Ohnishi H, Kurai D, Matsushima S, et al
    Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.
    J Clin Oncol. 2011;29:e191-2.
    PubMed     Text format     Related articles   
    
    
    
    
81. KO JH , Shih YC, Hui RC, Yang CH, et al
    Necrotizing vasculitis triggered by gefitinib: an unusual clinical presentation.
    J Clin Oncol. 2011;29:e169-70.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
82. KIDD MT , Karlin NJ, Cook CB
    Feminizing adrenal neoplasms: case presentations and review of the literature.
    J Clin Oncol. 2011;29:e127-30.
    PubMed     Text format     Related articles   
    
    
    
    
83. RUDIN CM , Mauer A, Smakal M, Juergens R, et al
    Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
84. GANDHI L , Camidge DR, Ribeiro de Oliveira M, Bonomi P, et al
    Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. NATALE RB , Thongprasert S, Greco FA, Thomas M, et al
    Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. DE BOER RH , Arrieta O, Yang CH, Gottfried M, et al
    Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. MORRIS PG , Gutin PH, Avila EK, Rosenblum MK, et al
    Seizures and Radionecrosis From Non-Small-Cell Lung Cancer Presenting as Increased Fluorodeoxyglucose Uptake on Positron Emission Tomography.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
88. ELLEGAST J , Barth TF, Schulte M, Bielack SS, et al
    Metastasis of osteosarcoma after 16 years.
    J Clin Oncol. 2011;29:e62-6.
    PubMed     Text format     Related articles   
    
    
    
    
89. TITULAER MJ , Maddison P, Sont JK, Wirtz PW, et al
    Clinical Dutch-English Lambert-Eaton Myasthenic Syndrome (LEMS) Tumor Association Prediction Score Accurately Predicts Small-Cell Lung Cancer in the LEMS.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. STUPP R , Betticher D, Ris HB, Peters S, et al
    Trimodality Therapy for Locally Advanced Non-Small-Cell Lung Cancer: A Curative Approach.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
91. RADHAKRISHNAN VS , Balaji J, Lakshminarasimhan S, Karkuzhali P, et al
    Unusual case of extrapulmonary metastatic recurrence in a patient with osteosarcoma.
    J Clin Oncol. 2011;29:e3-5.
    PubMed     Text format     Related articles   
    
    
    
    December 2010
92. ADDISON CL , Ding K, Zhao H, Le Maitre A, et al
    Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.
    J Clin Oncol. 2010;28:5247-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. CARNASSALE G , Margaritora S, Vita ML, Parisi AM, et al
    Lung Cancer in Association With Yellow Nail Syndrome.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
94. CORRAL J , Lopez-Villalobos JL, Gomez-Izquierdo L, Borrego I, et al
    Pathologic Complete Responses After Chemotherapy Plus Figitumumab in Stage IV Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
95. JOTTE R , Conkling P, Reynolds C, Galsky MD, et al
    Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. GORE EM , Bae K, Wong SJ, Sun A, et al
    Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non-Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. GHARWAN H , Erlich RB, Skaryak LA
    Non-Small-Cell Lung Cancer With Bronchopericardial Fistula Formation.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
98. SUN A , Bae K, Gore EM, Movsas B, et al
    Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non-Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. CHUNG KP , Shih JY, Yu CJ
    Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.
    J Clin Oncol. 2010;28:e701-3.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
100. NEUMANN H , Vieth M, Neurath MF, Fuchs FS, et al
     In Vivo Diagnosis of Small-Cell Lung Cancer by Endocytoscopy.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
101. KATHULA SK , Thomas DE, Anstadt MP, Khan AU, et al
     Paraneoplastic Cutaneous Leukocytoclastic Vasculitis and Iron Deficiency Anemia As the Presenting Features of Squamous Cell Lung Carcinoma.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
102. GAO JJ , Maricque BB, Morse MD, Huang W, et al
     Identification of autoantibodies in a patient with testicular cancer and concurrent inflammatory bowel disease.
     J Clin Oncol. 2010;28:e680-3.
     PubMed     Text format     Related articles   
     
     
     
     
103. OKAMOTO I , Yoshioka H, Morita S, Ando M, et al
     Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. LANGER CJ , Besse B, Gualberto A, Brambilla E, et al
     The Evolving Role of Histology in the Management of Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. DE RUYSSCHER D , Faivre-Finn C, Nestle U, Hurkmans CW, et al
     European Organization for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. PALMA D , Visser O, Lagerwaard FJ, Belderbos J, et al
     Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non-Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. FIDIAS P , Novello S
     Strategies for Prolonged Therapy in Patients With Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. YE T , Chen H, Hu H, Wang J, et al
     Malignant clear cell sugar tumor of the lung: patient case report.
     J Clin Oncol. 2010;28:e626-8.
     PubMed     Text format     Related articles   
     
     
     
     
109. JANKU F , Amin HM, Yang D, Garrido-Laguna I, et al
     Response of histiocytoses to imatinib mesylate: fire to ashes.
     J Clin Oncol. 2010;28:e633-6.
     PubMed     Text format     Related articles   
     
     
     
     October 2010
110. SUN Y , Ren Y, Fang Z, Li C, et al
     Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.
     J Clin Oncol. 2010;28:4616-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. SHIRAISHI K , Kohno T, Tanai C, Goto Y, et al
     Association of DNA Repair Gene Polymorphisms With Response to Platinum-Based Doublet Chemotherapy in Patients With Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. SEQUIST LV , Gettinger S, Senzer NN, Martins RG, et al
     Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. CARLSON LE , Groff SL, Maciejewski O, Bultz BD, et al
     Screening for Distress in Lung and Breast Cancer Outpatients: A Randomized Controlled Trial.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. HENEGHAN HM , Miller N, Kerin MJ
     Circulating miRNA signatures: promising prognostic tools for cancer.
     J Clin Oncol. 2010;28:e573-4.
     PubMed     Text format     Related articles   
     
     
     
     
115. HERBST RS , Kelly K, Chansky K, Mack PC, et al
     Phase II Selection Design Trial of Concurrent Chemotherapy and Cetuximab Versus Chemotherapy Followed by Cetuximab in Advanced-Stage Non-Small-Cell Lung Cancer: Southwest Oncology Group Study S0342.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. ROBERTS PJ , Stinchcombe TE, Der CJ, Socinski MA, et al
     Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy?
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. KEATING NL , Beth Landrum M, Arora NK, Malin JL, et al
     Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles?
     J Clin Oncol. 2010;28:4364-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
118. JOHNSON FM , Bekele BN, Feng L, Wistuba I, et al
     Phase II Study of Dasatinib in Patients With Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. BUIKHUISEN WA , Burgers JA, Vincent AD, Schellens JH, et al
     Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
     J Clin Oncol. 2010;28:e482-3.
     PubMed     Text format     Related articles   
     
     
     
     
120. FLORIANI I , Garassino MC, Broggini M, Veronese S, et al
     Role of cetuximab in the treatment of patients with NSCLC: are we throwing out the baby with the bath water?
     J Clin Oncol. 2010;28:e467.
     PubMed     Text format     Related articles   
     
     
     
     
121. WEI EK , Wolin KY, Colditz GA
     Time course of risk factors in cancer etiology and progression.
     J Clin Oncol. 2010;28:4052-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. ZHU CQ , Ding K, Strumpf D, Weir BA, et al
     Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. XIE Y , Minna JD
     Non-Small-Cell Lung Cancer mRNA Expression Signature Predicting Response to Adjuvant Chemotherapy.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
124. RUPPERT AM , Stankoff B, Lavole A, Gounant V, et al
     Miliary Brain Metastases in Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
125. KOSTOGLOU-ATHANASSIOU I , Athanassiou P, Gkountouvas A, Vecchini G, et al
     Thyroid Carcinosarcoma in a Patient With Lung Carcinoma.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
126. DILTS DM
     Early warning: an ailing canary in the mine.
     J Clin Oncol. 2010;28:3799-800.
     PubMed     Text format     Related articles   
     
     
     
     
127. TLEMCANI K , Levine D, Smith RV, Brandwein-Gensler M, et al
     Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
     J Clin Oncol. 2010;28:e412-4.
     PubMed     Text format     Related articles   
     
     
     
     
128. AYANIAN JZ , Zaslavsky AM, Arora NK, Kahn KL, et al
     Patients' Experiences With Care for Lung Cancer and Colorectal Cancer: Findings From the Cancer Care Outcomes Research and Surveillance Consortium.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
129. VALERIUS T
     Fcgamma receptor polymorphisms as biomarkers for epidermal growth factor receptor antibodies.
     J Clin Oncol. 2010;28:e393.
     PubMed     Text format     Related articles   
     
     
     
     
130. WANG L , Bi N
     TGF-{beta}1 Gene Polymorphisms for Anticipating Radiation-Induced Pneumonitis in Non-Small-Cell Lung Cancer: Different Ethnic Association.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
131. KELLY RJ , Carter C, Giaccone G
     Personalizing Therapy in an Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small-Cell Lung Cancer Using PF-00299804 and Trastuzumab.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
132. JIWNANI S , Karimundackal G, Pramesh CS
     Stereotactic Radiotherapy Versus Sublobar Lung Resection in Medically Unfit Patients With Early-Stage Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
133. WANG-GILLAM A , Williams K, Novello S, Gao F, et al
     Time to Activate Lung Cancer Clinical Trials and Patient Enrollment: A Representative Comparison Study Between Two Academic Centers Across the Atlantic.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. BRAHMER JR , Drake CG, Wollner I, Powderly JD, et al
     Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
     J Clin Oncol. 2010;28:3167-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
135. RATAIN MJ
     Bar the windows but open the door to randomization.
     J Clin Oncol. 2010;28:3104-6.
     PubMed     Text format     Related articles   
     
     
     
     April 2010
136. KROP IE , Beeram M, Modi S, Jones SF, et al
     Phase I Study of Trastuzumab-DM1, a HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. GOURLEY C , Michie CO, Roxburgh P, Yap TA, et al
     Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. NGAMPHAIBOON N , Pukiat S, Kandimalla Y, Hernandez-Ilizaliturri FJ, et al
     Diffuse Large B-Cell Lymphoma Presenting As Pancoast Tumor.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
139. TAKEDA M , Okamoto I, Fukuoka M, Nakagawa K, et al
     Successful Treatment With Erlotinib After Gefitinib-Related Severe Hepatotoxicity.
     J Clin Oncol. 2010.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: